1,015
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation

, , , , , , , & show all
Pages 201-214 | Received 28 Aug 2023, Accepted 08 Jan 2024, Published online: 02 Feb 2024